SFM
REGN icon

Signet Financial Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Signet Financial Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.01M Sell
3,895
-77
-2% -$59K 0.34% 97
2025
Q4 		$3.07M Sell
3,972
-23
-0.6% -$15.6K 0.34% 95
2025
Q3 		$2.25M Buy
3,995
+12
+0.3% +$6.79K 0.26% 114
2025
Q2 		$2.09M Sell
3,983
-20
-0.5% -$11.2K 0.26% 120
2025
Q1 		$2.54M Buy
4,003
+83
+2% +$57.1K 0.34% 97
2024
Q4 		$2.79M Sell
3,920
-110
-3% -$92.3K 0.36% 88
2024
Q3 		$4.24M Buy
4,030
+5
+0.1% +$5.56K 0.54% 56
2024
Q2 		$4.23M Buy
4,025
+5
+0.1% +$4.85K 0.57% 50
2024
Q1 		$3.87M Buy
4,020
+78
+2% +$74.2K 0.53% 60
2023
Q4 		$3.46M Sell
3,942
-1
-0% -$823 0.52% 61
2023
Q3 		$3.25M Sell
3,943
-46
-1% -$36.2K 0.54% 60
2023
Q2 		$2.87M Buy
3,989
+24
+0.6% +$18.5K 0.45% 71
2023
Q1 		$3.26M Buy
3,965
+11
+0.3% +$8.3K 0.55% 58
2022
Q4 		$2.85M Sell
3,954
-33
-0.8% -$24.3K 0.51% 64
2022
Q3 		$2.75M Buy
3,987
+20
+0.5% +$12.6K 0.54% 53
2022
Q2 		$2.35M Hold
3,967
– – 0.45% 65
2022
Q1 		$2.77M Buy
3,967
+51
+1% +$32.3K 0.46% 62
2021
Q4 		$2.47M Buy
3,916
+42
+1% +$25.8K 0.37% 70
2021
Q3 		$2.35M Buy
3,874
+11
+0.3% +$6.83K 0.4% 71
2021
Q2 		$2.16M Sell
3,863
-4
-0.1% -$2.03K 0.74% 33
2021
Q1 		$1.83M Sell
3,867
-129
-3% -$62.8K 0.34% 86
2020
Q4 		$1.93M Sell
3,996
-107
-3% -$57.8K 0.39% 78
2020
Q3 		$2.41M Sell
4,103
-200
-5% -$121K 0.53% 55
2020
Q2 		$2.62M Sell
4,303
-495
-10% -$281K 0.58% 54
2020
Q1 		$2.67M Sell
4,798
-605
-11% -$250K 0.63% 52
2019
Q4 		$2.03M Sell
5,403
-113
-2% -$38K 0.38% 84
2019
Q3 		$1.9M Sell
5,516
-355
-6% -$105K 0.37% 86
2019
Q2 		$1.81M Sell
5,871
-785
-12% -$261K 0.36% 88
2019
Q1 		$2.23M Sell
6,656
-248
-4% -$102K 0.44% 80
2018
Q4 		$2.58M Buy
6,904
+6,475
+1,509% +$2.37M 0.56% 69
2018
Q3 		$173K Buy
429
+28
+7% +$10.7K 0.03% 240
2018
Q2 		$138K Buy
+401
New +$125K 0.02% 270

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Signet Financial Management's REGN Position: Q1 2026 in Review

Signet Financial Management reduced its Regeneron Pharmaceuticals (REGN) stake by 1.9% in Q1 2026, selling an estimated $59K and leaving 3,895 shares worth $3.01M. The position accounts for 0.34% of the portfolio, ranked #97.

Signet Financial Management first reported a position in REGN in Q2 2018 and has held it in 32 quarters since. The position peaked at $4.24M in Q3 2024. 1,400 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Signet Financial Management held 3,895 shares of Regeneron Pharmaceuticals worth $3.01M as of Q1 2026.
  • Signet Financial Management sold 77 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $59K.
  • Regeneron Pharmaceuticals made up 0.34% of Signet Financial Management's portfolio in Q1 2026, its #97 holding.
  • Signet Financial Management first reported a position in Regeneron Pharmaceuticals in Q2 2018 and has held it in 32 quarters since.
  • Signet Financial Management's Regeneron Pharmaceuticals position peaked at $4.24M in Q3 2024.
  • 1,400 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Signet Financial Management's 13F filing for Q1 2026, filed 5 May 2026.